Sign up to save your podcasts
Or
Share Optimizing Treatment in Patients with ROS1 Rearranged NSCLC
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Optimizing Treatment in Patients with ROS1 Rearranged NSCLC
Optimizing Treatment in Patients with ROS1 Rearranged NSCLC episodes
- Introduction and Key Takeaways
This full educational program can be accessed at no cost here: https://annenberg.net/courses/landingPage.php?courseID=61030
15 min
About Optimizing Treatment in Patients with ROS1 Rearranged NSCLC
From the publisher's feed
Greater understanding and implementation of molecular biomarkers in non-small cell lung cancer (NSCLC) have led to improved patient outcomes. However, optimizing therapeutic strategies for patients…
with a molecular alteration continues to be challenging for the multidisciplinary team. Among these alterations, ROS1 rearrangements are rare, but have important clinical implications.